Menu Search
Equities

Shouyao Holdings Co Ltd

688197:SHH

Shouyao Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)31.07
  • Today's Change-0.93 / -2.91%
  • Shares traded529.36k
  • 1 Year change-29.45%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Shouyao Holdings Co Ltd had net income fall 6.76% from a loss of 173.82m to a larger loss of 185.57m despite a 186.18% increase in revenues from 1.83m to 5.23m. An increase in the cost of goods sold as a percentage of sales from 0.63% to 2.13% was a component in the falling net income despite rising revenues.
Gross margin95.40%
Net profit margin-4,847.44%
Operating margin-4,846.84%
Return on assets-17.49%
Return on equity-19.23%
Return on investment-19.17%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Shouyao Holdings Co Ltd fell by 659.25m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 179.57m for operations while cash used for investing totalled 474.48m.
Cash flow per share--
Price/Cash flow per share--
Book value per share6.17
Tangible book value per share6.17
More ▼

Balance sheet in CNYView more

Shouyao Holdings Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio7.48
Quick ratio7.47
Total debt/total equity0.0093
Total debt/total capital0.0093
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.